- €1.51bn
- €1.47bn
- €2.87bn
- 95
- 54
- 58
- 82
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,540 | 1,763 | 2,022 | 2,363 | 2,868 |
Cost of Revenue | |||||
Gross Profit | 281 | 333 | 432 | 544 | 666 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,487 | 1,699 | 1,938 | 2,248 | 2,725 |
Operating Profit | 52.7 | 63.9 | 84 | 114 | 143 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 48.3 | 60.2 | 80.8 | 109 | 128 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.4 | 42.2 | 56.8 | 78.6 | 90.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 29.3 | 37.9 | 52.3 | 73.5 | 84.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.3 | 37.9 | 52.3 | 73.5 | 84.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.89 | 2.42 | 3.32 | 4.57 | 5.35 |
Dividends per Share |